Matches in SemOpenAlex for { <https://semopenalex.org/work/W2295218603> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W2295218603 abstract "Abstract Background Cytogenetically normal acute myeloid leukemia (CN-AML) is the largest and most heterogeneous cytogenetic AML subgroup. For the practicing clinician it is difficult to know how to use the prognostic information of the growing number of clinical and molecular markers. Our purpose was to develop a widely applicable prognostic model by combining well-established pre-treatment patient and molecular characteristics. Patients and methods Two prognostic indices for CN-AML, one with regard to overall survival (PINAOS) and the other regarding relapse-free survival (PINARFS) were derived based on a cohort of 669 CN-AML patients treated within the AML Cooperative Group 99 (AMLCG99) study. Results Based on age (median: 60 years [range: 17-85 years]), performance status, white blood count, and presence or absence of NPM1 mutation, biallelic CEBPA mutation, and FLT3-ITD, patients were classified into three risk groups according to PINAOS and PINARFS: 29% of all and 32% of responding patients had low risk (5-year OS 72%; 5-year RFS 55%), 56% and 39% intermediate risk (5-year OS 28%; 5-year RFS 27%), and 15% and 29% high risk disease (5-year OS 3%; 5-year RFS 8%) (Figure 1). PINAOS and PINARFS further subdivided the European LeukemiaNet (ELN) favorable-genetic group as well as the ELN intermediate-I-genetic group. Both, PINAOS and PINARFS were confirmed in a large, independent, and comparable CN-AML cohort of 529 patients from the Cancer and Leukemia Group B (CALGB/Alliance) trials (Figure 2). Conclusions We have developed and validated the first prognostic indices specifically designed for CN-AML patients of all ages combining well-established molecular and clinical variables easily applicable in routine clinical care. The integration of both clinical and molecular markers could provide a basis for individualized patient care by risk-adapted therapy of CN-AML. Disclosures: No relevant conflicts of interest to declare." @default.
- W2295218603 created "2016-06-24" @default.
- W2295218603 creator A5002995654 @default.
- W2295218603 creator A5005460328 @default.
- W2295218603 creator A5008778599 @default.
- W2295218603 creator A5010845118 @default.
- W2295218603 creator A5012020159 @default.
- W2295218603 creator A5014917310 @default.
- W2295218603 creator A5022277766 @default.
- W2295218603 creator A5022616874 @default.
- W2295218603 creator A5025105470 @default.
- W2295218603 creator A5027358264 @default.
- W2295218603 creator A5033935778 @default.
- W2295218603 creator A5039118991 @default.
- W2295218603 creator A5053094064 @default.
- W2295218603 creator A5055512193 @default.
- W2295218603 creator A5055830086 @default.
- W2295218603 creator A5056151840 @default.
- W2295218603 creator A5058099757 @default.
- W2295218603 creator A5060976490 @default.
- W2295218603 creator A5062108544 @default.
- W2295218603 creator A5065426246 @default.
- W2295218603 creator A5071091625 @default.
- W2295218603 creator A5072021108 @default.
- W2295218603 creator A5081560063 @default.
- W2295218603 creator A5089611613 @default.
- W2295218603 creator A5090442302 @default.
- W2295218603 date "2013-11-15" @default.
- W2295218603 modified "2023-09-28" @default.
- W2295218603 title "A Combined Molecular and Clinical Prognostic Index For Relapse and Survival In Cytogenetically Normal AML (PINA)" @default.
- W2295218603 doi "https://doi.org/10.1182/blood.v122.21.1303.1303" @default.
- W2295218603 hasPublicationYear "2013" @default.
- W2295218603 type Work @default.
- W2295218603 sameAs 2295218603 @default.
- W2295218603 citedByCount "0" @default.
- W2295218603 crossrefType "journal-article" @default.
- W2295218603 hasAuthorship W2295218603A5002995654 @default.
- W2295218603 hasAuthorship W2295218603A5005460328 @default.
- W2295218603 hasAuthorship W2295218603A5008778599 @default.
- W2295218603 hasAuthorship W2295218603A5010845118 @default.
- W2295218603 hasAuthorship W2295218603A5012020159 @default.
- W2295218603 hasAuthorship W2295218603A5014917310 @default.
- W2295218603 hasAuthorship W2295218603A5022277766 @default.
- W2295218603 hasAuthorship W2295218603A5022616874 @default.
- W2295218603 hasAuthorship W2295218603A5025105470 @default.
- W2295218603 hasAuthorship W2295218603A5027358264 @default.
- W2295218603 hasAuthorship W2295218603A5033935778 @default.
- W2295218603 hasAuthorship W2295218603A5039118991 @default.
- W2295218603 hasAuthorship W2295218603A5053094064 @default.
- W2295218603 hasAuthorship W2295218603A5055512193 @default.
- W2295218603 hasAuthorship W2295218603A5055830086 @default.
- W2295218603 hasAuthorship W2295218603A5056151840 @default.
- W2295218603 hasAuthorship W2295218603A5058099757 @default.
- W2295218603 hasAuthorship W2295218603A5060976490 @default.
- W2295218603 hasAuthorship W2295218603A5062108544 @default.
- W2295218603 hasAuthorship W2295218603A5065426246 @default.
- W2295218603 hasAuthorship W2295218603A5071091625 @default.
- W2295218603 hasAuthorship W2295218603A5072021108 @default.
- W2295218603 hasAuthorship W2295218603A5081560063 @default.
- W2295218603 hasAuthorship W2295218603A5089611613 @default.
- W2295218603 hasAuthorship W2295218603A5090442302 @default.
- W2295218603 hasConcept C104317684 @default.
- W2295218603 hasConcept C126322002 @default.
- W2295218603 hasConcept C143998085 @default.
- W2295218603 hasConcept C2483381 @default.
- W2295218603 hasConcept C2778461978 @default.
- W2295218603 hasConcept C2778729363 @default.
- W2295218603 hasConcept C30481170 @default.
- W2295218603 hasConcept C45091340 @default.
- W2295218603 hasConcept C501734568 @default.
- W2295218603 hasConcept C53226629 @default.
- W2295218603 hasConcept C54355233 @default.
- W2295218603 hasConcept C71924100 @default.
- W2295218603 hasConcept C72563966 @default.
- W2295218603 hasConcept C86803240 @default.
- W2295218603 hasConceptScore W2295218603C104317684 @default.
- W2295218603 hasConceptScore W2295218603C126322002 @default.
- W2295218603 hasConceptScore W2295218603C143998085 @default.
- W2295218603 hasConceptScore W2295218603C2483381 @default.
- W2295218603 hasConceptScore W2295218603C2778461978 @default.
- W2295218603 hasConceptScore W2295218603C2778729363 @default.
- W2295218603 hasConceptScore W2295218603C30481170 @default.
- W2295218603 hasConceptScore W2295218603C45091340 @default.
- W2295218603 hasConceptScore W2295218603C501734568 @default.
- W2295218603 hasConceptScore W2295218603C53226629 @default.
- W2295218603 hasConceptScore W2295218603C54355233 @default.
- W2295218603 hasConceptScore W2295218603C71924100 @default.
- W2295218603 hasConceptScore W2295218603C72563966 @default.
- W2295218603 hasConceptScore W2295218603C86803240 @default.
- W2295218603 hasLocation W22952186031 @default.
- W2295218603 hasOpenAccess W2295218603 @default.
- W2295218603 hasPrimaryLocation W22952186031 @default.
- W2295218603 isParatext "false" @default.
- W2295218603 isRetracted "false" @default.
- W2295218603 magId "2295218603" @default.
- W2295218603 workType "article" @default.